Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study.

Kim KY, Miravitlles M, Sliwinski P, Costello R, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price D, Rhee CK.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 25;14:1595-1601. doi: 10.2147/COPD.S208245. eCollection 2019.

2.

Unique sleep-stage transitions determined by obstructive sleep apnea severity, age and gender.

Wächter M, Kantelhardt JW, Bonsignore MR, Bouloukaki I, Escourrou P, Fietze I, Grote L, Korzybski D, Lombardi C, Marrone O, Paranicova I, Pataka A, Ryan S, Schiza SE, Sliwinski P, Steiropoulos P, Verbraecken J, Penzel T; ESADA Study Group.

J Sleep Res. 2019 Jul 25:e12895. doi: 10.1111/jsr.12895. [Epub ahead of print]

PMID:
31347213
3.

Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA).

Gunduz C, Kacmaz Basoglu O, Hedner J, Bonsignore MR, Hein H, Staats R, Bouloukaki I, Roisman G, Pataka A, Sliwinski P, Ludka O, Pepin JL, Grote L; European Sleep Apnoea Database collaborators.

J Intern Med. 2019 Jul 1. doi: 10.1111/joim.12952. [Epub ahead of print]

PMID:
31260567
4.

Cancer prevalence is increased in females with sleep apnoea: data from the ESADA study.

Pataka A, Bonsignore MR, Ryan S, Riha RL, Pepin JL, Schiza S, Basoglu OK, Sliwinski P, Ludka O, Steiropoulos P, Anttalainen U, McNicholas WT, Hedner J, Grote L; ESADA study group.

Eur Respir J. 2019 Jun 20;53(6). pii: 1900091. doi: 10.1183/13993003.00091-2019. Print 2019 Jun. No abstract available.

PMID:
31109987
5.

Asthma-COPD Overlap-A Discordance Between Patient Populations Defined by Different Diagnostic Criteria.

Barczyk A, Maskey-Warzęchowska M, Górska K, Barczyk M, Kuziemski K, Śliwiński P, Batura-Gabryel H, Mróz R, Kania A, Obojski A, Tażbirek M, Celejewska-Wójcik N, Guziejko K, Brajer-Luftmann B, Korzybski D, Damps-Kostańska I, Krenke R.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2326-2336.e5. doi: 10.1016/j.jaip.2019.04.022. Epub 2019 Apr 26.

PMID:
31034998
6.

Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations.

Sakornsakolpat P, Prokopenko D, Lamontagne M, Reeve NF, Guyatt AL, Jackson VE, Shrine N, Qiao D, Bartz TM, Kim DK, Lee MK, Latourelle JC, Li X, Morrow JD, Obeidat M, Wyss AB, Bakke P, Barr RG, Beaty TH, Belinsky SA, Brusselle GG, Crapo JD, de Jong K, DeMeo DL, Fingerlin TE, Gharib SA, Gulsvik A, Hall IP, Hokanson JE, Kim WJ, Lomas DA, London SJ, Meyers DA, O'Connor GT, Rennard SI, Schwartz DA, Sliwinski P, Sparrow D, Strachan DP, Tal-Singer R, Tesfaigzi Y, Vestbo J, Vonk JM, Yim JJ, Zhou X, Bossé Y, Manichaikul A, Lahousse L, Silverman EK, Boezen HM, Wain LV, Tobin MD, Hobbs BD, Cho MH; SpiroMeta Consortium; International COPD Genetics Consortium.

Nat Genet. 2019 Mar;51(3):494-505. doi: 10.1038/s41588-018-0342-2. Epub 2019 Feb 25.

7.

Impact of polymorphism of selected genes on the diagnosis of type 2 diabetes in patients with obstructive sleep apnea.

Bielicki P, Pływaczewski R, Brzóska K, Kumor M, Barnaś M, Jonczak L, Stępkowski TM, Piechuta A, Chazan R, Śliwiński P, Kruszewski M.

Pol Arch Intern Med. 2019 Jan 31;129(1):6-11. doi: 10.20452/pamw.4406. Epub 2018 Dec 29.

8.

Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer.

Brzóska K, Bartłomiejczyk T, Sochanowicz B, Cymerman M, Grudny J, Kołakowski J, Kruszewski M, Śliwiński P, Roszkowski-Śliż K, Kapka-Skrzypczak L.

Oncol Lett. 2018 Nov;16(5):6831-6837. doi: 10.3892/ol.2018.9459. Epub 2018 Sep 19.

9.

Mandibular Advancement Devices in Obstructive Sleep Apnea Patients Intolerant to Continuous Positive Airway Pressure Treatment.

Wojda M, Kostrzewa-Janicka J, Śliwiński P, Bieleń P, Jurkowski P, Wojda R, Mierzwińska-Nastalska E.

Adv Exp Med Biol. 2019;1150:35-42. doi: 10.1007/5584_2018_275.

PMID:
30255301
10.

Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database.

Gündüz C, Basoglu OK, Hedner J, Zou D, Bonsignore MR, Hein H, Staats R, Pataka A, Barbe F, Sliwinski P, Kent BD, Pepin JL, Grote L; European Sleep Apnea Database Collaborators.

Respirology. 2018 Dec;23(12):1180-1189. doi: 10.1111/resp.13372. Epub 2018 Aug 21.

11.

Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial.

Warchol-Celinska E, Prejbisz A, Kadziela J, Florczak E, Januszewicz M, Michalowska I, Dobrowolski P, Kabat M, Sliwinski P, Klisiewicz A, Topor-Madry R, Narkiewicz K, Somers VK, Sobotka PA, Witkowski A, Januszewicz A.

Hypertension. 2018 Aug;72(2):381-390. doi: 10.1161/HYPERTENSIONAHA.118.11180. Epub 2018 Jun 25.

PMID:
29941516
12.

Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.

Miravitlles M, Sliwinski P, Rhee CK, Costello RW, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price DB.

Respir Med. 2018 Mar;136:8-14. doi: 10.1016/j.rmed.2018.01.019. Epub 2018 Jan 31.

PMID:
29501251
13.

Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.

Miravitlles M, Roche N, Cardoso J, Halpin D, Aisanov Z, Kankaanranta H, Kobližek V, Śliwiński P, Bjermer L, Tamm M, Blasi F, Vogelmeier CF.

Respir Res. 2018 Jan 18;19(1):11. doi: 10.1186/s12931-018-0715-1. Review.

14.

Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?

Wilson KC, Krishnan JA, Sliwinski P, Criner GJ, Miravitlles M, Hurst JR, Calverley PMA, Albert RK, Rigau D, Tonia T, Vestbo J, Papi A, Rabe KF, Anzueto A, Wedzicha JA.

Eur Respir J. 2018 Jan 11;51(1). pii: 1702577. doi: 10.1183/13993003.02577-2017. Print 2018 Jan. No abstract available.

15.

Severe COPD cases from Korea, Poland, and USA have substantial differences in respiratory symptoms and other respiratory illnesses.

Kim WJ, Yim JJ, Kim DK, Lee MG, Fuhlbrigge AL, Sliwinski P, Hawrylkiewicz I, Wan ES, Cho MH, Silverman EK.

Int J Chron Obstruct Pulmon Dis. 2017 Nov 30;12:3415-3423. doi: 10.2147/COPD.S145908. eCollection 2017.

16.

Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Wedzicha JA, Calverley PMA, Albert RK, Anzueto A, Criner GJ, Hurst JR, Miravitlles M, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JA.

Eur Respir J. 2017 Sep 9;50(3). pii: 1602265. doi: 10.1183/13993003.02265-2016. Print 2017 Sep.

17.

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Wedzicha JA Ers Co-Chair, Miravitlles M, Hurst JR, Calverley PM, Albert RK, Anzueto A, Criner GJ, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JA Ats Co-Chair.

Eur Respir J. 2017 Mar 15;49(3). pii: 1600791. doi: 10.1183/13993003.00791-2016. Print 2017 Mar.

18.

Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects.

Busch R, Hobbs BD, Zhou J, Castaldi PJ, McGeachie MJ, Hardin ME, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, Kim DK, Agusti A, Make BJ, Crapo JD, Calverley PM, Donner CF, Lomas DA, Wouters EF, Vestbo J, Tal-Singer R, Bakke P, Gulsvik A, Litonjua AA, Sparrow D, Paré PD, Levy RD, Rennard SI, Beaty TH, Hokanson J, Silverman EK, Cho MH; National Emphysema Treatment Trial Genetics; Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-Points; International COPD Genetics Network; COPDGene Investigators.

Am J Respir Cell Mol Biol. 2017 Jul;57(1):35-46. doi: 10.1165/rcmb.2016-0331OC.

19.

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis.

Hobbs BD, de Jong K, Lamontagne M, Bossé Y, Shrine N, Artigas MS, Wain LV, Hall IP, Jackson VE, Wyss AB, London SJ, North KE, Franceschini N, Strachan DP, Beaty TH, Hokanson JE, Crapo JD, Castaldi PJ, Chase RP, Bartz TM, Heckbert SR, Psaty BM, Gharib SA, Zanen P, Lammers JW, Oudkerk M, Groen HJ, Locantore N, Tal-Singer R, Rennard SI, Vestbo J, Timens W, Paré PD, Latourelle JC, Dupuis J, O'Connor GT, Wilk JB, Kim WJ, Lee MK, Oh YM, Vonk JM, de Koning HJ, Leng S, Belinsky SA, Tesfaigzi Y, Manichaikul A, Wang XQ, Rich SS, Barr RG, Sparrow D, Litonjua AA, Bakke P, Gulsvik A, Lahousse L, Brusselle GG, Stricker BH, Uitterlinden AG, Ampleford EJ, Bleecker ER, Woodruff PG, Meyers DA, Qiao D, Lomas DA, Yim JJ, Kim DK, Hawrylkiewicz I, Sliwinski P, Hardin M, Fingerlin TE, Schwartz DA, Postma DS, MacNee W, Tobin MD, Silverman EK, Boezen HM, Cho MH; COPDGene Investigators; ECLIPSE Investigators; LifeLines Investigators; SPIROMICS Research Group; International COPD Genetics Network Investigators; UK BiLEVE Investigators; International COPD Genetics Consortium.

Nat Genet. 2017 Mar;49(3):426-432. doi: 10.1038/ng.3752. Epub 2017 Feb 6.

20.

Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment.

Jóźwik-Plebanek K, Prejbisz A, Wypasek E, Pręgowska-Chwała B, Hanus K, Kaszuba AM, Januszewicz M, Bieleń P, Kabat M, Kruk M, Dobrowolski P, Klisiewicz A, Śliwiński P, Januszewicz A, Undas A.

J Hypertens. 2017 May;35(5):1035-1043. doi: 10.1097/HJH.0000000000001269.

PMID:
28141659
21.

Mandibular Advancement Appliance for Obstructive Sleep Apnea Treatment.

Kostrzewa-Janicka J, Śliwiński P, Wojda M, Rolski D, Mierzwińska-Nastalska E.

Adv Exp Med Biol. 2017;944:63-71. Review.

PMID:
27826882
22.

Clinical Phenotypes and Comorbidity in European Sleep Apnoea Patients.

Saaresranta T, Hedner J, Bonsignore MR, Riha RL, McNicholas WT, Penzel T, Anttalainen U, Kvamme JA, Pretl M, Sliwinski P, Verbraecken J, Grote L; ESADA Study Group.

PLoS One. 2016 Oct 4;11(10):e0163439. doi: 10.1371/journal.pone.0163439. eCollection 2016.

23.

Efficacy and safety of aclidinium/formoterol versus salmeterol/fluticasone: a phase 3 COPD study.

Vogelmeier C, Paggiaro PL, Dorca J, Sliwinski P, Mallet M, Kirsten AM, Beier J, Seoane B, Segarra RM, Leselbaum A.

Eur Respir J. 2016 Oct;48(4):1030-1039. doi: 10.1183/13993003.00216-2016. Epub 2016 Aug 4.

24.

Standards for diagnosis and care of patients with inherited alpha-1 antitrypsin deficiency Recommendations of the Polish Respiratory Society, Polish Society of Pediatric Pulmonology and Polish Society of Pediatric Gastroenterology.

Chorostowska-Wynimko J, Bakuła A, Kulus M, Kuca P, Niżankowska-Mogilnicka E, Sanak M, Socha P, Śliwiński P.

Pneumonol Alergol Pol. 2016;84(3):193-202. doi: 10.5603/PiAP.2016.0023. No abstract available.

25.

Pulmonary artery dilation indicates severe obstructive sleep apnea in patients with resistant hypertension: the Resist-POL Study.

Dobrowolski P, Florczak E, Klisiewicz A, Prejbisz A, Rybicka J, Śliwiński P, Januszewicz A, Hoffman P.

Pol Arch Med Wewn. 2016 Apr 29;126(4):222-9. doi: 10.20452/pamw.3388. Epub 2016 Apr 29.

26.

Venous thromboembolism and sarcoidosis: co-incidence or coexistence?

Goljan-Geremek A, Geremek M, Puscinska E, Sliwinski P.

Cent Eur J Immunol. 2015;40(4):477-80. doi: 10.5114/ceji.2015.56972. Epub 2016 Jan 15. Review.

27.

A review of national guidelines for management of COPD in Europe.

Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, Kankaanranta H, Sandström T, Śliwiński P, Zatloukal J, Blasi F.

Eur Respir J. 2016 Feb;47(2):625-37. doi: 10.1183/13993003.01170-2015. Epub 2016 Jan 21. Review.

28.

Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease.

Hobbs BD, Parker MM, Chen H, Lao T, Hardin M, Qiao D, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, Kim DK, Castaldi PJ, Hersh CP, Morrow J, Celli BR, Pinto-Plata VM, Criner GJ, Marchetti N, Bueno R, Agustí A, Make BJ, Crapo JD, Calverley PM, Donner CF, Lomas DA, Wouters EF, Vestbo J, Paré PD, Levy RD, Rennard SI, Zhou X, Laird NM, Lin X, Beaty TH, Silverman EK, Cho MH; NETT Genetics Investigators; ECLIPSE Investigators; COPDGene Investigators; International COPD Genetics Network Investigators.

Am J Respir Crit Care Med. 2016 Jul 1;194(1):48-57. doi: 10.1164/rccm.201510-2053OC.

29.

Obstructive sleep apnea in severe mental disorders.

Szaulińska K, Pływaczewski R, Sikorska O, Holka-Pokorska J, Wierzbicka A, Wichniak A, Śliwiński P.

Psychiatr Pol. 2015;49(5):883-95. doi: 10.12740/PP/32566. Review. English, Polish.

30.

Pilot program on distance training in spirometry testing - the technology feasibility study.

Nowiński A, Romański E, Bieleń P, Bednarek M, Puścińska E, Goljan-Geremek A, Pływaczewski R, Śliwinski P.

Pneumonol Alergol Pol. 2015;83(6):431-5. doi: 10.5603/PiAP.2015.0071.

31.

The influence of comorbidities on mortality in sarcoidosis: a observational prospective cohort study.

Nowiński A, Puścińska E, Goljan A, Peradzynska J, Bednarek M, Korzybski D, Kamiński D, Stokłosa A, Czystowska M, Śliwiński P, Górecka D.

Clin Respir J. 2017 Sep;11(5):648-656. doi: 10.1111/crj.12398. Epub 2015 Nov 18.

PMID:
26470754
32.

Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.

Szpechcinski A, Chorostowska-Wynimko J, Struniawski R, Kupis W, Rudzinski P, Langfort R, Puscinska E, Bielen P, Sliwinski P, Orlowski T.

Br J Cancer. 2015 Jul 28;113(3):476-83. doi: 10.1038/bjc.2015.225. Epub 2015 Jun 30.

33.

Causes of deaths in COPD patients in primary care setting--a 6-year follow-up.

Pływaczewski R, Maciejewski J, Bednarek M, Zieliński J, Górecka D, Śliwiński P.

Pneumonol Alergol Pol. 2015;83(3):193-202. doi: 10.5603/PiAP.2015.0031.

34.

The national alpha-1 antitrypsin deficiency registry in Poland.

Chorostowska-Wynimko J, Struniawski R, Sliwinski P, Wajda B, Czajkowska-Malinowska M.

COPD. 2015 May;12 Suppl 1:22-6. doi: 10.3109/15412555.2015.1021915.

PMID:
25938287
35.
36.

Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study.

Goljan-Geremek A, Bednarek M, Franczuk M, Puścińska E, Nowiński A, Czystowska M, Kamiński D, Korzybski D, Stokłosa A, Kowalska A, Wojda E, Sliwiński P, Burakowska B, Ptak J, Barańska I, Drygalska A, Małek G, Bestry I, Wesołowski S, Kram M, Górecka D.

Pneumonol Alergol Pol. 2014;82(6):518-33. doi: 10.5603/PiAP.2014.0069.

37.

Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.

Brzóska K, Bartłomiejczyk T, Sochanowicz B, Cymerman M, Grudny J, Kołakowski J, Kapka-Skrzypczak L, Kruszewski M, Sliwiński P, Roszkowski-Śliż K.

Ann Agric Environ Med. 2014;21(3):546-51. doi: 10.5604/12321966.1120599.

38.

Independent association of obstructive sleep apnea with left ventricular geometry and systolic function in resistant hypertension: the RESIST-POL study.

Dobrowolski P, Klisiewicz A, Florczak E, Prejbisz A, Bieleń P, Sliwiński P, Kabat M, Rybicka J, Topór-Mądry R, Januszewicz A, Hoffman P.

Sleep Med. 2014 Nov;15(11):1302-8. doi: 10.1016/j.sleep.2014.06.015. Epub 2014 Aug 19.

PMID:
25260432
39.

Factors associated with diastolic dysfunction in patients with resistant hypertension: resist-POL study.

Dobrowolski P, Klisiewicz A, Prejbisz A, Florczak E, Rybicka J, Bieleń P, Śliwiński P, Gosk M, Januszewicz A, Hoffman P.

Am J Hypertens. 2015 Mar;28(3):307-11. doi: 10.1093/ajh/hpu150. Epub 2014 Aug 26.

PMID:
25159084
40.

Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study.

Tkacova R, McNicholas WT, Javorsky M, Fietze I, Sliwinski P, Parati G, Grote L, Hedner J; European Sleep Apnoea Database study collaborators.

Eur Respir J. 2014 Oct;44(4):931-41. doi: 10.1183/09031936.00225113. Epub 2014 Aug 7.

41.

[Genetic predisposition to ischemic heart disease in patients with obstructive sleep apnea syndrome (OSAS)].

Bielicki P, Brzóska K, Pływaczewski R, Barnaś M, Kumor M, Stepkowski T, Jończak L, Chazan R, Kruszewski M, Sliwiński P.

Pol Merkur Lekarski. 2014 Apr;36(214):229-32. Polish.

PMID:
24868893
42.

[Influence of inhaler and fine particle on efficacy of inhalation therapy in COPD].

Sliwiński P, Chazan R, Dąbrowiecki P, Jahnz-Różyk K, Mróz R, Pirożyński M.

Pneumonol Alergol Pol. 2014;82(3):300-10. doi: 10.5603/PiAP.2014.0035. Review. Polish.

43.

[Polish respiratory society guidelines for chronic obstructive pulmonary disease].

Sliwiński P, Górecka D, Jassem E, Pierzchała W.

Pneumonol Alergol Pol. 2014;82(3):227-63. doi: 10.5603/PiAP.2014.0030. Polish. No abstract available.

44.

Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study.

Kent BD, Grote L, Bonsignore MR, Saaresranta T, Verbraecken J, Lévy P, Sliwinski P, Tkacova R, Kvamme JA, Fietze I, Hedner J, McNicholas WT; European Sleep Apnoea Database collaborators.

Eur Respir J. 2014 Jul;44(1):130-9. doi: 10.1183/09031936.00162713. Epub 2014 Apr 2.

45.

Relationship between obstructive sleep apnea and markers of cardiovascular alterations in never-treated hypertensive patients.

Prejbisz A, Florczak E, Pręgowska-Chwała B, Klisiewicz A, Kuśmierczyk-Droszcz B, Zieliński T, Makowiecka-Cieśla M, Kołodziejczyk-Kruk S, Śliwiński P, Januszewicz A.

Hypertens Res. 2014 Jun;37(6):573-9. doi: 10.1038/hr.2014.43. Epub 2014 Mar 13.

PMID:
24621467
46.

Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.

Remels AH, Gosker HR, Langen RC, Polkey M, Sliwinski P, Galdiz J, van den Borst B, Pansters NA, Schols AM.

Biochim Biophys Acta. 2014 Feb;1842(2):175-85. doi: 10.1016/j.bbadis.2013.11.001. Epub 2013 Nov 8.

47.

Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension.

Prejbisz A, Florczak E, Klisiewicz A, Dobrowolski P, Janaszek-Sitkowska H, Bieleń P, Szwench-Pietrasz E, Warchoł-Celińska E, Kołodziejczyk-Kruk S, Janas J, Kabat M, Imiela J, Sliwiński P, Januszewicz A.

Endokrynol Pol. 2013;64(5):363-7. doi: 10.5603/EP.2013.0019.

48.

Association of genetic dependences between lung cancer and chronic obstructive pulmonary disease.

Grudny J, Kołakowski J, Kruszewski M, Szopiński J, Sliwiński P, Wiatr E, Winek J, Załęska J, Zych J, Roszkowski-Śliż K.

Pneumonol Alergol Pol. 2013;81(4):308-18.

49.

Clinical characteristics of patients with resistant hypertension: the RESIST-POL study.

Florczak E, Prejbisz A, Szwench-Pietrasz E, Sliwiński P, Bieleń P, Klisiewicz A, Michałowska I, Warchoł E, Januszewicz M, Kała M, Witkowski A, Więcek A, Narkiewicz K, Somers VK, Januszewicz A.

J Hum Hypertens. 2013 Nov;27(11):678-85. doi: 10.1038/jhh.2013.32. Epub 2013 May 23.

PMID:
23698004
50.

[EUROPEAN COPD AUDIT in Poland--how do we treat the patients with COPD exacerbation?].

Chorostowska-Wynimko J, Górecka D, Sliwiński P, Roszkowski-Śliż K.

Pneumonol Alergol Pol. 2012;80(6):493-7. Polish. No abstract available.

Supplemental Content

Loading ...
Support Center